Evidence map›Paper›PMID 34547873›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2021

[A predictive model based on risk factors for early mortality in patients with newly diagnosed multiple myeloma].

M R Tian, P Y Yang, T T Yue, M Y Li, Y J Zhang, M X Zhang, L M Zhang, Y R Yan, Z L Hu, Y Z Du and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

M R TianDepartment of Hematology, the First Hospital of Jilin University, Changchun 130021, China.
P Y YangDepartment of Hematology, the First Hospital of Jilin University, Changchun 130021, China.
T T YueDepartment of Hematology, the First Hospital of Jilin University, Changchun 130021, China.
M Y LiDepartment of Hematology, the First Hospital of Jilin University, Changchun 130021, China.
Y J ZhangDepartment of Hematology, the First Hospital of Jilin University, Changchun 130021, China.
M X ZhangDepartment of Hematology, the First Hospital of Jilin University, Changchun 130021, China.
L M ZhangDepartment of Hematology, the First Hospital of Jilin University, Changchun 130021, China.
Y R YanDepartment of Hematology, the First Hospital of Jilin University, Changchun 130021, China.
Z L HuDepartment of Hematology, the First Hospital of Jilin University, Changchun 130021, China.
Y Z DuDepartment of Hematology, the First Hospital of Jilin University, Changchun 130021, China.
Y Y LiDepartment of Hematology, the First Hospital of Jilin University, Changchun 130021, China.
F Y JinDepartment of Hematology, the First Hospital of Jilin University, Changchun 130021, China.

Funding

The National Natural Science Foundation of China 81670190
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Multiple MyelomaAgedHumansMaleNeoplasm Recurrence, LocalPrognosisRetrospective StudiesRisk FactorsEarly mortalityMultiple myelomaPredictive modelRisk factors

Identifiers

PMID34547873
PMCPMC8501273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.